Mi-Helper’s neuromodulation technology has the potential to be an at-home, non-invasive therapy for the treatment of migraine. Results from their prior clinical trial suggest that neuromodulation through transnasal air flow is promising, and may provide patients with relief from associated head pain and symptoms. As a longstanding advisor for Mi-Helper, I am excited to see its impact on migraine-related outcomes
5
Stewart J. Tepper, MD, FAHS
Vice President
The New England Institute for Neurology and Headache, Stamford, CT
